The challenges of the homeless haemophilia patient

被引:0
|
作者
Lambing, A. [1 ]
Kuriakose, P. [1 ]
Kachalsky, E. [1 ]
Mueller, L. [1 ]
机构
[1] Henry Ford Hlth Syst, Hematol Oncol, Detroit, MI 48202 USA
关键词
challenge; haemophilia; health care; homeless; HEALTH-CARE; PEOPLE; NEEDS;
D O I
10.1111/hae.12124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The current economic hardships within the United States can increase the risk of persons becoming homeless. In 2001, it was estimated that between 0.1% and 2.1% of the population were homeless every night and that 2.3 - 3.5 million persons could become homeless every year [1]. Many issues can increase the risk of homelessness including: home foreclosure, declining work force due to declining wages, low-wage opportunities and less secure jobs, decline in public assistance, lack of affordable housing with limited housing assistance programs, poverty, lack of affordable health care, domestic violence, mental illness, and addiction disorders. Many on the streets may suffer from mental illness, developmental disabilities, and or chronic physical illness [6]. Given these issues, the Hemophilia Treatment Center (HTC) can expect to experience the issue of homelessness within their own population of persons with hemophilia. Currently, there are no studies that address the issue of the person with hemophilia who may become homeless. This presents unique challenges that this population may encounter to survive in addition to managing bleeding issues related to the diagnosis of hemophilia. This article will review the issues related to homelessness in the general population. Two case studies of persons with hemophilia who became homeless will be discussed outlining the strategies utilized to assist the patient during this crisis.
引用
收藏
页码:546 / 550
页数:5
相关论文
共 50 条
  • [11] Care of the Homeless Patient
    Klein, Jared Wilson
    Reddy, Simha
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2015, 99 (05) : 1017 - +
  • [12] Overcoming the challenges in gene therapy for haemophilia
    VandenDriessche, T.
    Nair, N.
    Di Matteo, M.
    Petrus, Inge
    Le Guiner, C.
    Blouin, V.
    De Bleser, P.
    Willems, J.
    Rincon, M.
    Sarcar, S.
    Samara-Kuko, E.
    Matrai, J.
    Cantore, A.
    Basner-Tschakarjan, E.
    Ward, N.
    Waddington, S.
    Mc Vey, J.
    Moullier, P.
    Naldini, L.
    High, K.
    Mingozzi, F.
    Chuah, M. K. L.
    [J]. HUMAN GENE THERAPY, 2013, 24 (12) : A26 - A26
  • [13] Chemical synovectomy in haemophilia:: status and challenges
    Rivard, GÉ
    [J]. HAEMOPHILIA, 2001, 7 : 16 - 19
  • [14] Sports and exercise in haemophilia: benefits and challenges
    Riske, B.
    [J]. HAEMOPHILIA, 2007, 13 : 29 - 30
  • [15] Challenges and controversies in haemophilia care in adulthood
    Dolan, G.
    Hermans, C.
    Klamroth, R.
    Madhok, R.
    Schutgens, R. E. G.
    Spengler, U.
    [J]. HAEMOPHILIA, 2009, 15 : 20 - 27
  • [16] Challenges in the treatment of haemophilia with inhibitors - Introduction
    Aledort, LM
    [J]. HAEMOPHILIA, 1999, 5 : IV - IV
  • [17] Challenges in the treatment of haemophilia with inhibitors - Conclusion
    White, GC
    [J]. HAEMOPHILIA, 1999, 5 : 51 - 51
  • [18] Challenges to manage cardiovascular diseases in haemophilia
    Schutgens, R. E. G.
    [J]. HAEMOPHILIA, 2011, 17 (02) : 347 - 347
  • [19] Haemophilia gene therapy: Progress and challenges
    Lheriteau, Elsa
    Davidoff, Andrew M.
    Nathwani, Amit C.
    [J]. BLOOD REVIEWS, 2015, 29 (05) : 321 - 328
  • [20] Comorbidity in the aging haemophilia patient
    Mauser-Bunschoten, E.
    Roosendaal, G.
    Schutgens, R.
    Fischer, K.
    [J]. HAEMOPHILIA, 2008, 14 : 128 - 128